Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Umeå University
- University of Basel
- Nature Careers
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- VIB
- Academic Europe
- Cancer Research Foundation of the University of Salamanca
- Duke University
- Fundació Sant Joan de Déu
- Harvard University
- Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
- Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB)
- King's College London
- Leibniz
- Linköping University
- Polish Academy of Sciences Institute of Medical Biology
- Technical University of Munich
- Universitat de Barcelona
- University of Bergen
- University of Copenhagen
- University of Massachusetts Medical School
- University of Oslo
- Univerzita Palackého v Olomouci
- Uppsala universitet
- 14 more »
- « less
-
Field
-
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences | Czech | about 1 month ago
cultured cells, genetics (CRISPR and RNAi), proteomics, and cell biological techniques ranging from microscopy to in vitro biochemical approaches, aiming to elucidate basic principles of membrane protein
-
2022, bringing together a diverse consortium of more than a dozen world-leading scientists in RNA modification and delivery, CRISPR-Cas systems, microRNAs, non-coding RNA, RNA biology of infections, and
-
-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything
-
-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything
-
to include a letter of motivation detailing research interests and expertise and a CV. Previous knowledge of genome stability and CRISPR/Cas9 methodology is required. In addition, you should have experience in
-
data. We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in vivo during developmental and disease. These technologies are a game-changer in the speed
-
University of Massachusetts Medical School | Worcester, Massachusetts | United States | 2 months ago
of these candidates to determine how they regulate pericyte specification. For all projects, we routinely develop and apply cutting-edge approaches, including conditional genetics, CRISPR-based gene editing, single
-
data. We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in vivo during developmental and disease. These technologies are a game-changer in the speed
-
-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything
-
such as Imaris or similar) is required. Experience with proximity ligation assays and CRISPR/Cas9 is highly desirable. Experience with single-cell RNA sequencing and downstream data analysis is highly